Sage Journals: Discover world-class research

Open access

Research article

First published 2025

Comparative evaluation of STRATIFY JCV™ and IMMUNOWELL™ assays for anti-JCV antibody detection in natalizumab-treated RRMS patients

Clara Grazia Chisari, Giulio Spampinato, Pina Crimì [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2016-7

PML risk stratification using anti-JCV antibody index and L-selectin

Nicholas Schwab, Tilman Schneider-Hohendorf, Béatrice Pignolet [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2020-7

Anti-JCV antibody index does not change during ocrelizumab-treatment

Torge Rempe, Aaron Carlson, Augusto Miravalle [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2015-10

Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy

Anke Vennegoor, Johannis A van Rossum, Chris H Polman [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2025-6

A comparison of JC virus assay performance provided with originator and biosimilar natalizumab

James Varley, Rahma Beyrouti, Richard Nicholas [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2013-10

Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort

Tomas Olsson, Anat Achiron, Lars Alfredsson [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2025-6

Beyond the switch to the biosimilar of natalizumab: What is the impact of changing the JCV test?

Sandra Vukusic, Florian Hubben, Antoine Gavoille [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2015-12

Anti-JC virus antibody titres increase over time with natalizumab treatment

J Raffel, AR Gafson, O Malik [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2012-8

Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision

Carmen Tur, Mar Tintoré, Angela Vidal-Jordana [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2018-7

High prevalence and indexes of anti-John Cunningham virus antibodies in a cohort of Chinese patients with multiple sclerosis

Alexander Lau, Wei Qiu, Allan Kermode [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Search results